CVS Health Announces Formulary and Therapy Strategy for PCSK9 Inhibitors
November 23, 2015 at 08:06 AM EST
CVS Health (NYSE: CVS) announced today that Repatha™ (evolocumab) from Amgen Inc. will be added as the only PCSK9 inhibitor on the ...